Decibel Therapeutics, Inc. Operating Cash Flow
Decibel Therapeutics, Inc. reported Operating Cash Flow of -$27.32 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-08-11
- Decibel Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$10.27M.
- Decibel Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$17.06M.
- Decibel Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$7.77M.
- Decibel Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$13.72M.
- Decibel Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$56.90M.
- Decibel Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$43.15M.
- Decibel Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$32.66M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$10.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$27.32M 10-Q · filed 2023-08-11 | -$35.09M derived: sum of 3 quarters · filed 2023-08-11 | -$48.81M derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | -$17.06M 10-Q · filed 2023-05-15 | -$24.82M derived: sum of 2 quarters · filed 2023-05-15 | -$38.54M derived: sum of 3 quarters · filed 2023-05-15 | -$51.95M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | -$7.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$21.48M derived: sum of 2 quarters · filed 2023-03-14 | -$34.89M derived: sum of 3 quarters · filed 2023-08-11 | -$56.90M 10-K · filed 2023-03-14 |
| 2022-09-30 | -$13.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$27.13M derived: sum of 2 quarters · filed 2023-08-11 | -$49.13M 10-Q · filed 2022-11-09 | -$58.68M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-06-30 | -$13.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$35.41M 10-Q · filed 2023-08-11 | -$44.96M derived: sum of 3 quarters · filed 2023-08-11 | -$56.61M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$22.01M 10-Q · filed 2023-05-15 | -$31.55M derived: sum of 2 quarters · filed 2023-05-15 | -$43.20M derived: sum of 3 quarters · filed 2023-05-15 | -$48.85M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$9.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$21.20M derived: sum of 2 quarters · filed 2023-03-14 | -$26.84M derived: sum of 3 quarters · filed 2023-03-14 | -$43.15M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$11.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$17.30M derived: sum of 2 quarters · filed 2022-11-09 | -$33.60M 10-Q · filed 2022-11-09 | -$38.75M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$5.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$21.95M 10-Q · filed 2022-08-10 | -$27.10M derived: sum of 3 quarters · filed 2022-08-10 | -$34.79M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$16.31M 10-Q · filed 2022-05-12 | -$21.45M derived: sum of 2 quarters · filed 2022-05-12 | -$29.14M derived: sum of 3 quarters · filed 2022-05-12 | -$37.06M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$12.83M derived: sum of 2 quarters · filed 2022-03-18 | -$20.75M derived: sum of 3 quarters · filed 2022-03-18 | -$32.66M 10-K · filed 2022-03-18 |
| 2020-09-30 | -$7.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$15.61M derived: sum of 2 quarters · filed 2021-11-10 | -$27.51M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$7.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$19.83M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$11.91M 10-Q · filed 2021-05-13 |